Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Volunteers

NCT ID: NCT05153837

Last Updated: 2025-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-30

Study Completion Date

2023-08-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Human digestive system physiologically ensures the absorption of oral water and hydration of the human body. Water is quickly absorbed by the digestive tract with a peak between 15 and 20 minutes. It has demonstrated that oral water remains the best hydration solution that have an effect on plasma volume expansion and cardiovascular system during exercise. While the cardiovascular effect of fluid expansion by saline serum is well known (venous return, preload and cardiac output), effect of oral water varies in the literature depending on the physiological state of the patient and the clinical state. Thus, the investigators aim to investigate oral water effects on fluid responsiveness, regional blood flow and microcirculatory changes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intravenous Fluids Pharmacodynamics Fluid Therapy Fluid Responsiveness Fluid Challenge

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

oral water

Experimental group: oral administration of 500 ml of water.

Group Type EXPERIMENTAL

oral water

Intervention Type OTHER

500 ml oral water

intravenous

Active comparator: Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route

Group Type ACTIVE_COMPARATOR

saline intravenous administration

Intervention Type OTHER

Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

saline intravenous administration

Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route

Intervention Type OTHER

oral water

500 ml oral water

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteer subject between 18 and 30 years old
* patient with a regular sinus rhythm
* Echogenic subject.
* Fasting of solid and liquid since 8 h
* Subject in regular sinus rhythm.
* Written consent signed.

Exclusion Criteria

* Any known cardiac, renal or endocrine pathology.
* Arrhythmia rhythm disorder by atrial fibrillation
* Pregnant or nursing woman.
* Pathology versus indicating Nacl administration.
* Person under tutors or curators or deprived of liberty.
* Person not affiliated to a social security scheme.
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens-Picardie

Amiens, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI2019_843_0064

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effectiveness of Aquamin® in Mitigating Halitosis
NCT05058638 ACTIVE_NOT_RECRUITING PHASE2
Measurements of Water in Breath and Saliva
NCT03233256 ENROLLING_BY_INVITATION NA
Local Pilocarpine for Relieving Dry Mouth
NCT04195100 COMPLETED EARLY_PHASE1